Synthesis and anthelmintic activity of some hybrid benzimidazolyl-chalcone derivatives

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 6, 2011, Pages 767-775

  Ouattara, Mahama ^a   Sissouma, Drissa ^a   Koné, Mamidou W ^b,c   Menan, Hervé E ^a   Touré, Seikou A ^a   Ouattara, Lassina ^a  

^a UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^b CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^c UNIVERSITÉ NANGUI ABROGOUA   (Côte d’Ivoire)

Author keywords

Anthelmintic activity; Benzimidazole; Chalcone; Haemonchus contortus

Indexed keywords

1 (1H BENZIMIDAZOL 2 YL) 3 ARYL 2 PROPEN 1 ONE DERIVATIVE; ANTHELMINTIC AGENT; BENZIMIDAZOLYL CHALCONE DERIVATIVE; FENBENDAZOLE; IVERMECTIN; UNCLASSIFIED DRUG;

ANTHELMINTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HAEMONCHUS CONTORTUS; IN VITRO STUDY; LARVA; MASS SPECTROMETRY; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 83455228422     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i6.10     Document Type: Article

References (17)

1. Horton J. Global anthelmintic chemotherapy programmes: learning from history. Trends Parasitol 2003; 9(9): 403-409.
2. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest 2008; 118(4): 1311-1321.
3. Geerts S, Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin Microbiol Rev 2000; 13(3): 207-222.
4. Waller PJ. (a) The future of anthelmintics in sustainable parasite control programs for livestock. Helminthologia 2003; 40: 97-102.
5. Perry BD, Randolph RF, McDermott JJ, Sones KR, Thornton PK. Investing in animal health research to alleviate poverty. International Livestock Research Institute, Nairobi, Kenya, 2002. 148 p.
6. Kwa MS, Veenstra JG, Roos MH. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1. Mol Biochem Parasitol 1994; 63(2): 299-303.
7. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths. Trends Parasitol 2004; 20(10): 469-476.
8. James CE, Hudson AL, Davey MW. Drug resistance mechanisms in helminths: is it survival of the fittest? Trends Parasitol 2009; 25(7): 328-335.
9. Newton SE, Munn EA. The Development of Vaccines against Gastrointestinal Nematode Parasites, Particularly Haemonchus contortus. Parasitol Today 1999; 15(3): 116-122.
10. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem 1999; 6(12): 1125-1149.
11. Nowakowska Z. A review of anti-infective and antiinflammatory chalcones. Eur J Med Chem 2007; 42(2): 125-137.
12. Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN, Davidson E, Kurzban G, Miller RE, Nuzum EO, et al. In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 1995; 38(26): 5031-5037.
13. Awasthi SK, Mishra N, Dixit SK, Singh A, Marshleen Yadav M, Yadav SS, Rathaur S. Antifilarial Activity of 1,3-Diarylpropen-1-One: Effect on Glutathione-S-Transferase, a Phase II Detoxification Enzyme. Am J Trop Med Hyg 2009; 80(5): 764-768.
14. Jacobs DE, Taylor MA. Drugs used in the treatment and control of parasitic infections. In: Bishop, J. editors. The Veterinary Formulary, Fifth ed. Pharmaceutical Press, London; 2001. p. 219-245.
15. Rramaiah K, Grossert JS, Hooper DL, Dubey PK, Ramanatham J. Studies on synthesis of 2- acetylbenzimidazole and related benzimidazole derivatives. J Indian Chem Soc 1999; 76(3): 140-144.
16. Phillips MA. The formation of 2-substituted benziminazoles. J Am Soc 1928: 2393-2399.
17. Velík J, Baliharová V, Fink-Gremmels J, Bull S, Lamka J, Skálová L. Benzimidazole drugs and modulation of biotransformation enzymes. Res Vet Sci 2004; 76(2): 95-108.